Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMAGINutrition is a small U.S.-based nutritional technology and consulting company focused on innovation, intellectual property, clinical research, and science-driven product development in dietary supplements, medical foods, beverages, cosmetics, and related wellness categories. The company appears to operate more as a consultancy and product-development think tank than as a drug-development biotech with a disclosed therapeutic pipeline. Public descriptions link the business closely to founder Anthony L. Almada, who is identified as founder, president, and CSO. Available sources indicate the company has supported strategic clinical research, evidence-based marketing, and product innovation for health and nutrition products rather than advancing named pharmaceutical assets. Corporate-registration data indicate the California entity is currently suspended, suggesting the company is not an active good-standing operating corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMAGINutrition.